![]() |
市场调查报告书
商品编码
2005686
全球整形外科植入契约製造市场报告:2021年至2032年历史资料及预测Global Orthopedic Implant Contract Manufacturing Market Report, History and Forecast 2021-2032 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
本报告中,全球整形外科植入契约製造市场指的是为整形外科OEM製造商外包植入肌肉骨骼医疗设备的工业化和生产。这包括机械加工、锻造、铸造、增材製造、涂层、精加工及相关製造支持,但不包括单一器械、托盘和包装盒、电动工具、机器人硬体以及其他非植入整形外科产品。这一范围与本报告中「仅限植入」的市场定义以及主要整形外科外包供应商就其整合製造能力所作的公开声明相一致。
根据本报告提出的市场模型,全球整形外科植入契约製造市场预计将从2021年的46.0303亿美元增长到2025年的77.0667亿美元,到2032年达到186.5448亿美元,2021年至2025年的复合年增长率为186.5448亿美元,2021年至2025年的复合年增长率为13.8323232123年。因此,随着外包在整个整形外科植入专案中渗透率的不断提高以及製造流程日益复杂,该市场预计将保持强劲的中期成长势头。
按地区划分,北美仍然是最大的市场,市场规模将从2025年的43.6074亿美元增长到2032年的96.1369亿美元,而欧洲则保持其第二大区域市场的地位。亚太地区是主要区域中成长最快的,市场规模将从2025年的7.442亿美元成长到2032年的28.738亿美元,同期其销售份额也将从9.66%成长到15.41%。这表明,儘管北美和欧洲仍然是市场的主要支撑,但未来的成长将越来越依赖亚洲主导。
按製造方法划分,「棒材和板材加工」将在2025年成为最大的细分市场,规模达26.097亿美元,这反映了其在众多整形外科植入类别中的广泛应用。然而,最重要的结构性成长驱动因素将是“增材製造+后处理”,其规模将从2025年的14.741亿美元增长到2032年的55.9535亿美元,市场份额也将从19.13%增长到29.99%。到2032年,积层製造的销售额将略微超过棒材和板材加工,这表明植入製造流程正明显朝着更复杂、高附加价值且对形状设计要求更高的方向发展。
按应用领域划分,大型关节仍是最大的终端市场,预计将从2025年的28.1748亿美元成长到2032年的63.1858亿美元。脊椎是第二大细分市场,也是最具吸引力的成长领域之一,预计将从22.2435亿美元成长到57.8128亿美元,市占率也将从28.86%上升到30.99%。肢体、小关节和运动医学植入虽然基数较小,但其成长速度也超过了许多成熟领域,这表明外包需求正在超越传统的重组专案。
竞争依然激烈,市场高度分散。截至2025年,主要企业包括Orchid Orthopedic Solutions、Marle、Cretex、Tecomet和AMETEK(Paragon Medical),但这五家公司合计仅占全球销售额的14.19%,其余供应商占据了79.89%的市场份额。总体而言,本报告指出,整形外科植入契约製造市场在2032年之前前景乐观,成长动力主要来自OEM厂商持续的外包、对专业製程的需求以及增材製造、表面处理和其他技术先进的植入製造领域不断提升的附加价值。
本报告旨在全面概述全球整形外科植入契约製造市场,并结合定量和定性分析。其目标是帮助读者制定业务/成长策略、评估市场竞争、分析自身当前市场地位,并就整形外科植入植入契约製造做出明智的商业决策。
为了更深入了解市场,本报告提供了竞争格局、主要竞争对手及其市场排名的概况,并探讨了技术趋势和新产品开发。
本报告旨在帮助读者了解产业竞争格局,以及如何在竞争激烈的环境中拓展潜在利润。报告重点分析全球整形外科植入契约製造市场的竞争格局,详细介绍主要企业的市场份额、行业排名、竞争对手生态系统、市场表现、新产品开发、业务状况、扩张和收购活动。这有助于读者识别主要竞争对手,并深入了解市场竞争模式。
市场区隔
本报告按公司、类型、应用、地区和国家/地区对整形外科植入契约製造市场进行了分析,提供了历史时期和预测期(2021-2026 年、2027-2032 年,以 2024 年为基准年)的市场规模和复合年增长率 (CAGR)。报告也指出了各细分市场的潜在商机,并说明了该市场极具吸引力的投资提案矩阵。
公司
按类型分類的细分市场
特定用途的剪辑
按地区
The global orthopedic implant contract manufacturing market in this report is defined as the outsourced industrialization and production of implantable musculoskeletal devices for orthopedic OEMs, including machining, forging, casting, additive manufacturing, coating, finishing, and related manufacturing support, while excluding standalone instruments, trays and cases, powered tools, robotics hardware, and other non-implant orthopedic products. This scope is consistent with both the report's implant-only market definition and the way major orthopedic outsourcing suppliers publicly describe their integrated manufacturing capabilities.
Based on the report's market model, the global orthopedic implant contract manufacturing market increased from US$4,603.03 million in 2021 to US$7,706.67 million in 2025, and is forecast to reach US$18,654.48 million by 2032, representing a 13.8% CAGR in 2021-2025 and 13.4% CAGR in 2026-2032. The market therefore remains on a strong medium-term growth trajectory, supported by expanding outsourcing penetration and rising manufacturing complexity across orthopedic implant programs.
From a regional perspective, North America remains the largest market, rising from US$4,360.74 million in 2025 to US$9,613.69 million by 2032, while Europe remains the second-largest regional market. Asia-Pacific is the fastest-growing major region, expanding from US$744.20 million in 2025 to US$2,873.80 million in 2032, with its revenue share increasing from 9.66% to 15.41% over the same period. This indicates that while the market remains anchored in North America and Europe, future incremental growth is becoming increasingly Asia-led.
By manufacturing route, Bar & Plate Machining is the largest segment in 2025 at US$2,609.70 million, reflecting its broad applicability across orthopedic implant categories. However, Additive Manufacturing + Post-processing is the most important structural growth engine, rising from US$1,474.10 million in 2025 to US$5,595.35 million in 2032, with segment share increasing from 19.13% to 29.99%. By 2032, additive manufacturing slightly surpasses Bar & Plate Machining in revenue share, indicating a clear shift toward more complex, higher-value, geometry-intensive implant manufacturing workflows.
By application, Large Joints remain the largest end market, growing from US$2,817.48 million in 2025 to US$6,318.58 million in 2032. Spine is the second-largest segment and one of the most attractive growth areas, increasing from US$2,224.35 million to US$5,781.28 million, while its share rises from 28.86% to 30.99%. Extremities & Small Joints and Sports Medicine Implantables also grow faster than many mature categories from smaller bases, indicating that outsourcing demand is broadening beyond traditional reconstruction programs.
Competitive intensity remains high and the market is notably fragmented. In 2025, the leading companies include Orchid Orthopedic Solutions, Marle, Cretex, Tecomet, and AMETEK (Paragon Medical), but the top five together account for only 14.19% of global revenue, while the long tail of other suppliers represents 79.89% of the market. Overall, the report suggests that the orthopedic implant contract manufacturing market offers a favorable outlook through 2032, with growth driven by continued OEM outsourcing, demand for specialist processes, and increasing value capture in additive, surface-engineering, and other technically demanding implant manufacturing segments.
This report aims to provide a comprehensive presentation of the global market for Orthopedic Implant Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthopedic Implant Contract Manufacturing.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedic Implant Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Orthopedic Implant Contract Manufacturing segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2021-2026, 2027-2032), considering 2024 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2026, 2027-2032). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Orthopedic Implant Contract Manufacturing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion